do laboratories limited Company Information
Company Number
07684007
Next Accounts
Apr 2025
Shareholders
project00 ltd
Group Structure
View All
Industry
Non-trading company
Registered Address
217 mare street, hackney, london, E8 3QE
Website
www.bio-logix.comdo laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of DO LABORATORIES LIMITED at £22.5k based on a Turnover of £54.6k and 0.41x industry multiple (adjusted for size and gross margin).
do laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of DO LABORATORIES LIMITED at £343.8k based on an EBITDA of £105.3k and a 3.26x industry multiple (adjusted for size and gross margin).
do laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of DO LABORATORIES LIMITED at £12.6k based on Net Assets of £9.6k and 1.31x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Do Laboratories Limited Overview
Do Laboratories Limited is a live company located in london, E8 3QE with a Companies House number of 07684007. It operates in the non-trading company sector, SIC Code 74990. Founded in June 2011, it's largest shareholder is project00 ltd with a 100% stake. Do Laboratories Limited is a established, micro sized company, Pomanda has estimated its turnover at £54.6k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Do Laboratories Limited Health Check
Pomanda's financial health check has awarded Do Laboratories Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs


2 Strong

1 Regular

7 Weak

Size
annual sales of £54.6k, make it smaller than the average company (£3.4m)
- Do Laboratories Limited
£3.4m - Industry AVG

Growth
3 year (CAGR) sales growth of -14%, show it is growing at a slower rate (4.5%)
- Do Laboratories Limited
4.5% - Industry AVG

Production
with a gross margin of 18%, this company has a higher cost of product (35%)
- Do Laboratories Limited
35% - Industry AVG

Profitability
an operating margin of 192.9% make it more profitable than the average company (4.8%)
- Do Laboratories Limited
4.8% - Industry AVG

Employees
with 1 employees, this is below the industry average (42)
1 - Do Laboratories Limited
42 - Industry AVG

Pay Structure
on an average salary of £40.1k, the company has an equivalent pay structure (£40.1k)
- Do Laboratories Limited
£40.1k - Industry AVG

Efficiency
resulting in sales per employee of £54.6k, this is less efficient (£147.2k)
- Do Laboratories Limited
£147.2k - Industry AVG

Debtor Days
it gets paid by customers after 89 days, this is later than average (41 days)
- Do Laboratories Limited
41 days - Industry AVG

Creditor Days
its suppliers are paid after 27 days, this is quicker than average (40 days)
- Do Laboratories Limited
40 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Do Laboratories Limited
- - Industry AVG

Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Do Laboratories Limited
- - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 28.4%, this is a lower level of debt than the average (47.6%)
28.4% - Do Laboratories Limited
47.6% - Industry AVG
DO LABORATORIES LIMITED financials

Do Laboratories Limited's latest turnover from July 2023 is estimated at £54.6 thousand and the company has net assets of £9.6 thousand. According to their latest financial statements, Do Laboratories Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jun 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||
Other Income Or Grants | ||||||||||||
Cost Of Sales | ||||||||||||
Gross Profit | ||||||||||||
Admin Expenses | ||||||||||||
Operating Profit | ||||||||||||
Interest Payable | ||||||||||||
Interest Receivable | ||||||||||||
Pre-Tax Profit | ||||||||||||
Tax | ||||||||||||
Profit After Tax | ||||||||||||
Dividends Paid | ||||||||||||
Retained Profit | ||||||||||||
Employee Costs | ||||||||||||
Number Of Employees | 1 | 1 | 2 | 2 | 3 | 3 | 3 | 4 | ||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jun 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 52 | 52 | 52 | |||||||||
Intangible Assets | ||||||||||||
Investments & Other | 376,052 | 376,052 | 376,052 | 376,052 | 376,052 | 376,052 | 376,002 | 376,002 | 376,002 | |||
Debtors (Due After 1 year) | ||||||||||||
Total Fixed Assets | 52 | 52 | 52 | 376,052 | 376,052 | 376,052 | 376,052 | 376,052 | 376,052 | 376,002 | 376,002 | 376,002 |
Stock & work in progress | ||||||||||||
Trade Debtors | 13,400 | 15,940 | 28,209 | 18,593 | 22,262 | 27,262 | 65,663 | 90,886 | 92,300 | 3,140 | 3,140 | 100 |
Group Debtors | ||||||||||||
Misc Debtors | 694 | 293 | 842 | 69 | ||||||||
Cash | 1,605 | 308 | 28 | 322 | 7,609 | 2,284 | 6,266 | 2,994 | ||||
misc current assets | ||||||||||||
total current assets | 13,400 | 15,940 | 28,209 | 20,892 | 22,863 | 28,132 | 65,985 | 98,564 | 94,584 | 9,406 | 6,134 | 100 |
total assets | 13,452 | 15,992 | 28,261 | 396,944 | 398,915 | 404,184 | 442,037 | 474,616 | 470,636 | 385,408 | 382,136 | 376,102 |
Bank overdraft | ||||||||||||
Bank loan | ||||||||||||
Trade Creditors | 3,326 | 84,849 | 93,432 | 1,656 | 350 | 1,747 | 940 | 526 | 505,012 | 420,486 | 384,088 | 378,056 |
Group/Directors Accounts | 457,509 | 463,713 | 464,620 | 464,620 | 496,343 | |||||||
other short term finances | ||||||||||||
hp & lease commitments | ||||||||||||
other current liabilities | 3,451 | 3,389 | 9,200 | 8,140 | 11,588 | |||||||
total current liabilities | 3,326 | 84,849 | 93,432 | 462,616 | 467,452 | 475,567 | 473,700 | 508,457 | 505,012 | 420,486 | 384,088 | 378,056 |
loans | ||||||||||||
hp & lease commitments | ||||||||||||
Accruals and Deferred Income | 500 | 500 | 500 | |||||||||
other liabilities | ||||||||||||
provisions | ||||||||||||
total long term liabilities | 500 | 500 | 500 | |||||||||
total liabilities | 3,826 | 85,349 | 93,932 | 462,616 | 467,452 | 475,567 | 473,700 | 508,457 | 505,012 | 420,486 | 384,088 | 378,056 |
net assets | 9,626 | -69,357 | -65,671 | -65,672 | -68,537 | -71,383 | -31,663 | -33,841 | -34,376 | -35,078 | -1,952 | -1,954 |
total shareholders funds | 9,626 | -69,357 | -65,671 | -65,672 | -68,537 | -71,383 | -31,663 | -33,841 | -34,376 | -35,078 | -1,952 | -1,954 |
Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jun 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||
Operating Profit | ||||||||||||
Depreciation | ||||||||||||
Amortisation | ||||||||||||
Tax | ||||||||||||
Stock | ||||||||||||
Debtors | -2,540 | -12,269 | 8,922 | -3,268 | -5,549 | -37,559 | -25,292 | -1,345 | 89,160 | 3,040 | 100 | |
Creditors | -81,523 | -8,583 | 91,776 | 1,306 | -1,397 | 807 | 414 | -504,486 | 84,526 | 36,398 | 6,032 | 378,056 |
Accruals and Deferred Income | -2,951 | 62 | -5,811 | 1,060 | -3,448 | 11,588 | ||||||
Deferred Taxes & Provisions | ||||||||||||
Cash flow from operations | ||||||||||||
Investing Activities | ||||||||||||
capital expenditure | ||||||||||||
Change in Investments | -376,052 | 50 | 376,002 | |||||||||
cash flow from investments | ||||||||||||
Financing Activities | ||||||||||||
Bank loans | ||||||||||||
Group/Directors Accounts | -457,509 | -6,204 | -907 | -31,723 | 496,343 | |||||||
Other Short Term Loans | ||||||||||||
Long term loans | ||||||||||||
Hire Purchase and Lease Commitments | ||||||||||||
other long term liabilities | ||||||||||||
share issue | ||||||||||||
interest | ||||||||||||
cash flow from financing | ||||||||||||
cash and cash equivalents | ||||||||||||
cash | -1,605 | 1,297 | 280 | -294 | -7,287 | 5,325 | -3,982 | 3,272 | 2,994 | |||
overdraft | ||||||||||||
change in cash | -1,605 | 1,297 | 280 | -294 | -7,287 | 5,325 | -3,982 | 3,272 | 2,994 |
do laboratories limited Credit Report and Business Information
Do Laboratories Limited Competitor Analysis

Perform a competitor analysis for do laboratories limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in E 8 area or any other competitors across 12 key performance metrics.
do laboratories limited Ownership
DO LABORATORIES LIMITED group structure
Do Laboratories Limited has 1 subsidiary company.
Ultimate parent company
1 parent
DO LABORATORIES LIMITED
07684007
1 subsidiary
do laboratories limited directors
Do Laboratories Limited currently has 2 directors. The longest serving directors include Ms Alice Fung (Jun 2011) and Mr Joost Beunderman (Mar 2013).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Alice Fung | England | 46 years | Jun 2011 | - | Director |
Mr Joost Beunderman | England | 46 years | Mar 2013 | - | Director |
P&L
July 2023turnover
54.6k
-58%
operating profit
105.3k
0%
gross margin
18.1%
+19.63%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
July 2023net assets
9.6k
-1.14%
total assets
13.5k
-0.16%
cash
0
0%
net assets
Total assets minus all liabilities
do laboratories limited company details
company number
07684007
Type
Private limited with Share Capital
industry
74990 - Non-trading company
incorporation date
June 2011
age
14
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
July 2023
previous names
N/A
accountant
ASHTON MCGILL
auditor
-
address
217 mare street, hackney, london, E8 3QE
Bank
-
Legal Advisor
-
do laboratories limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to do laboratories limited.
do laboratories limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DO LABORATORIES LIMITED. This can take several minutes, an email will notify you when this has completed.
do laboratories limited Companies House Filings - See Documents
date | description | view/download |
---|